Related Experiment Video
Updated: Jun 10, 2026
Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays
Published on: November 12, 2012
Determination of hypersensitivity to genotoxic agents among Escherichia coli single gene knockout mutants
Elinne Becket1, Frank Chen, Cindy Tamae
1Department of Microbiology, Immunology, and Molecular Genetics, University of California-Los Angeles, CA 90095, USA.
Abstract:
We have tested the KEIO collection of 3985 different viable single gene knockouts in Escherichia coli to identify genes whose loss increases sensitivity to one or more of six different chemotherapeutic agents and mutagens: Bleomycin (BLM), Cisplatin (CPT), ICR-191 (ICR), 5-azacytidine (5AZ), Zebularine (ZEB), and 5-bromo-2'-deoxyuridine (5BdU). We discovered a set of 156 strains that display a significant increase in sensitivity to at least one of the agents tested. Each genotoxic agent generates a distinct "sensitivity profile" that is characteristic of the agent. Comparison with an independent study of sensitivity profiles for an extensive set of antibiotics pinpoints those effects that are relatively specific for each agent. In some cases engineered double mutants have greatly increased effects. These results provide insight into the mechanism of action of each agent, and define targets for the design of co-drugs that can potentiate these agents. An example is the finding that mutants lacking one of several genes in the folate biosynthetic pathway are hypersensitive to ZEB, leading to a demonstration of synergy between trimethoprim and ZEB.
Insights
Researchers screened 3,985 gene knockout strains in E. coli to find sensitivities to chemotherapeutics. They identified 156 strains with increased sensitivity, revealing distinct agent profiles and potential co-drug targets.
Area of Science:
- Microbiology
- Genetics
- Pharmacology
Background:
- Understanding gene function is crucial for drug development.
- High-throughput screening of gene knockouts can identify novel drug sensitivities.
- Escherichia coli is a model organism for genetic studies.
Purpose of the Study:
- To identify genes in Escherichia coli whose absence confers sensitivity to chemotherapeutic agents.
- To characterize the distinct sensitivity profiles of six different genotoxic agents.
- To uncover potential targets for co-drug development.
Main Methods:
- Screening of the KEIO collection (3985 single gene knockouts) in E. coli.
- Testing sensitivity to Bleomycin (BLM), Cisplatin (CPT), ICR-191 (ICR), 5-azacytidine (5AZ), Zebularine (ZEB), and 5-bromo-2 -deoxyuridine (5BdU).
- Comparative analysis of sensitivity profiles with existing antibiotic sensitivity data.
Main Results:
- Identified 156 strains exhibiting increased sensitivity to at least one agent.
- Each genotoxic agent demonstrated a unique sensitivity profile.
- Observed potentiated effects in some engineered double mutants.
- Highlighted folate biosynthesis pathway genes' role in Zebularine sensitivity.
Conclusions:
- The study provides insights into the mechanisms of action for tested chemotherapeutic agents.
- Distinct sensitivity profiles can guide the development of targeted co-drugs.
- Synergy between trimethoprim and Zebularine was demonstrated, validating the approach.
